Low average selling prices and high production costs across all markets negatively impacted Japfa Group’s Animal Protein Other (APO) segment. The segment’s revenue in H1 2023 saw a slight 1.1% decrease to USD 500.6 million. APO-Vietnam’s performance during the period continued to be affected by mar...
Sign in as a member, or Join our Community for free to unlock the full article.
Low average selling prices and high production costs across all markets negatively impacted Japfa Group’s Animal Protein Other (APO) segment. The segment’s revenue in H1 2023 saw a slight 1.1% decrease to USD 500.6 million. APO-Vietnam’s performance during the period continued to be affected by mar...
Sign in as a member, or Join our Community for free to unlock the full article.
Low average selling prices and high production costs across all markets negatively impacted Japfa Group’s Animal Protein Other (APO) segment. The segment’s revenue in H1 2023 saw a slight 1.1% decrease to USD 500.6 million. APO-Vietnam’s performance during the period continued to be affected by mar...
Sign in as a member, or Join our Community for free to unlock the full article.
Low average selling prices and high production costs across all markets negatively impacted Japfa Group’s Animal Protein Other (APO) segment. The segment’s revenue in H1 2023 saw a slight 1.1% decrease to USD 500.6 million. APO-Vietnam’s performance during the period continued to be affected by mar...
Sign in as a member, or Join our Community for free to unlock the full article.
Low average selling prices and high production costs across all markets negatively impacted Japfa Group’s Animal Protein Other (APO) segment. The segment’s revenue in H1 2023 saw a slight 1.1% decrease to USD 500.6 million. APO-Vietnam’s performance during the period continued to be affected by mar...
Sign in as a member, or Join our Community for free to unlock the full article.
Low average selling prices and high production costs across all markets negatively impacted Japfa Group’s Animal Protein Other (APO) segment. The segment’s revenue in H1 2023 saw a slight 1.1% decrease to USD 500.6 million. APO-Vietnam’s performance during the period continued to be affected by mar...
Sign in as a member, or Join our Community for free to unlock the full article.
Low average selling prices and high production costs across all markets negatively impacted Japfa Group’s Animal Protein Other (APO) segment. The segment’s revenue in H1 2023 saw a slight 1.1% decrease to USD 500.6 million. APO-Vietnam’s performance during the period continued to be affected by mar...
Sign in as a member, or Join our Community for free to unlock the full article.
Low average selling prices and high production costs across all markets negatively impacted Japfa Group’s Animal Protein Other (APO) segment. The segment’s revenue in H1 2023 saw a slight 1.1% decrease to USD 500.6 million. APO-Vietnam’s performance during the period continued to be affected by mar...
Sign in as a member, or Join our Community for free to unlock the full article.
Low average selling prices and high production costs across all markets negatively impacted Japfa Group’s Animal Protein Other (APO) segment. The segment’s revenue in H1 2023 saw a slight 1.1% decrease to USD 500.6 million. APO-Vietnam’s performance during the period continued to be affected by mar...
Sign in as a member, or Join our Community for free to unlock the full article.
Low average selling prices and high production costs across all markets negatively impacted Japfa Group’s Animal Protein Other (APO) segment. The segment’s revenue in H1 2023 saw a slight 1.1% decrease to USD 500.6 million. APO-Vietnam’s performance during the period continued to be affected by mar...
Sign in as a member, or Join our Community for free to unlock the full article.
Low average selling prices and high production costs across all markets negatively impacted Japfa Group’s Animal Protein Other (APO) segment. The segment’s revenue in H1 2023 saw a slight 1.1% decrease to USD 500.6 million. APO-Vietnam’s performance during the period continued to be affected by mar...
Sign in as a member, or Join our Community for free to unlock the full article.
Low average selling prices and high production costs across all markets negatively impacted Japfa Group’s Animal Protein Other (APO) segment. The segment’s revenue in H1 2023 saw a slight 1.1% decrease to USD 500.6 million. APO-Vietnam’s performance during the period continued to be affected by mar...
Sign in as a member, or Join our Community for free to unlock the full article.
Low average selling prices and high production costs across all markets negatively impacted Japfa Group’s Animal Protein Other (APO) segment. The segment’s revenue in H1 2023 saw a slight 1.1% decrease to USD 500.6 million. APO-Vietnam’s performance during the period continued to be affected by mar...
Sign in as a member, or Join our Community for free to unlock the full article.
Low average selling prices and high production costs across all markets negatively impacted Japfa Group’s Animal Protein Other (APO) segment. The segment’s revenue in H1 2023 saw a slight 1.1% decrease to USD 500.6 million. APO-Vietnam’s performance during the period continued to be affected by mar...
Sign in as a member, or Join our Community for free to unlock the full article.
Low average selling prices and high production costs across all markets negatively impacted Japfa Group’s Animal Protein Other (APO) segment. The segment’s revenue in H1 2023 saw a slight 1.1% decrease to USD 500.6 million. APO-Vietnam’s performance during the period continued to be affected by mar...
Sign in as a member, or Join our Community for free to unlock the full article.
Low average selling prices and high production costs across all markets negatively impacted Japfa Group’s Animal Protein Other (APO) segment. The segment’s revenue in H1 2023 saw a slight 1.1% decrease to USD 500.6 million. APO-Vietnam’s performance during the period continued to be affected by mar...
Sign in as a member, or Join our Community for free to unlock the full article.
Low average selling prices and high production costs across all markets negatively impacted Japfa Group’s Animal Protein Other (APO) segment. The segment’s revenue in H1 2023 saw a slight 1.1% decrease to USD 500.6 million. APO-Vietnam’s performance during the period continued to be affected by mar...
Sign in as a member, or Join our Community for free to unlock the full article.
ASIAN AGRIBUSINESS MEDIA PTE LTD
Would you like to join your colleagues in the Asian Agribiz Community. Click here to JOIN NOW!
